IFT57 抗体
(Intraflagellar Transport 57 Homolog (IFT57))
Required for the formation of cilia. May also have pro- apoptotic function (By similarity).
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| IFT57 抗体 (Internal Region) | 人, 小鼠, 大鼠, 犬 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 170-429) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 1-429) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 214-312) | 人 | 小鼠 Monoclonal |
|
|
|
| IFT57 抗体 (AA 159-193) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 214-312) | 人 | 小鼠 Polyclonal |
|
|
|
| IFT57 抗体 (Internal Region) | 人, 小鼠 | 山羊 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (AbBy Fluor® 594) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| IFT57 抗体 (AA 331-429) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 犬
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 170-429
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-429
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1G8
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 214-312
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB57869
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 159-193
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 214-312
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 594
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 331-429
Latest Publications for our IFT57 抗体
: "DEAD-box helicase DDX27 regulates 3' end formation of ribosomal 47S RNA and stably associates with the PeBoW-complex." in: Experimental cell research, Vol. 334, Issue 1, pp. 146-59, (2015) (PubMed).
: "Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI)." in: Journal of molecular biology, Vol. 375, Issue 5, pp. 1197-205, (2008) (PubMed).
: "Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors." in: The Journal of cell biology, Vol. 170, Issue 2, pp. 191-200, (2005) (PubMed).
: "Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1." in: Molecular and cellular biology, Vol. 24, Issue 10, pp. 4329-40, (2004) (PubMed).
: "HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains." in: The Journal of biological chemistry, Vol. 279, Issue 14, pp. 14294-306, (2004) (PubMed).
: "Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI)." in: Journal of molecular biology, Vol. 375, Issue 5, pp. 1197-205, (2008) (PubMed).
: "Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors." in: The Journal of cell biology, Vol. 170, Issue 2, pp. 191-200, (2005) (PubMed).
: "Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1." in: Molecular and cellular biology, Vol. 24, Issue 10, pp. 4329-40, (2004) (PubMed).
: "HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains." in: The Journal of biological chemistry, Vol. 279, Issue 14, pp. 14294-306, (2004) (PubMed).
Aliases for IFT57 抗体
intraflagellar transport 57 (Ift57) 抗体intraflagellar transport 57 (IFT57) 抗体
intraflagellar transport 57 S homeolog (ift57.S) 抗体
4833420A15Rik 抗体
Esrrbl1 抗体
ESRRBL1 抗体
Hippi 抗体
HIPPI 抗体
MHS4R2 抗体
您还需要查找其他产品吗？
You are here:
